65LAB awards US$1.5 million to Duke-NUS platform to advance antifibrotic drug discovery
Recipient Professor Enrico Petretto from Duke-NUS is spearheading groundbreaking research to develop new drugs for lung disease and uncover new therapeutic targets for kidney
